+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-02-03Number of Pages: 105

Dermatology Diagnostic Devices and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

As the incidence of chronic skin conditions such as psoriasis, acne, rosacea, eczema, cell carcinoma, pruritus, and dermatitis increases globally, in return it will create opportunities for the expansion of the dermatology diagnostic devices and therapeutics market.  Besides, having an adverse impact on the well-being of millions, these diseases also put burden on an economy’s healthcare finances. As per Transparency Market Research (TMR), skin conditions such as these permeate all cultures, they can occur at any age, and affects 30% to 70% individuals globally. The situation necessitates the efficient research and development on novel dermatology therapeutics.

The global dermatology diagnostic devices and therapeutics market will therefore gain from the rising prevalence of such chronic ailments, increasing geriatric population, and the changing pool of patients. However, with the implementation of the Affordable Care Act and the looming patent expirations, the growth trajectory of the market is likely to be hindered to an extent. Nevertheless, TMR projects positive growth for the market between 2015 and 2023.

Rising at a CAGR of 6.9% between 2015 and 2023, the global market for dermatology diagnostic devices is poised to reach US$1 bn 2023, from a valuation of US$0.6 bn in 2014. Conversely, the global dermatology therapeutics market is projected to expand at a CAGR of 1.9% during the forecast period, rising from a valuation of US$17.5 bn in 2014 to US$20.1 bn in 2023.

North America Emerges at Fore of Global Dermatology Diagnostic Devices and Therapeutics Market

Regionally, North America has emerged at the fore of the dermatology diagnostic devices and therapeutics market. The region constituted a share of 43.8% in 2014, thus sealing its dominance in the global market. Besides witnessing a growing prevalence of skin disorders, North America also boasts easy access to best-in-class healthcare facilities. This makes the region very lucrative for most companies operating in the market. Growth witnessed by the dermatology diagnostic devices and therapeutics market in the region has been a result of the presence of a highly structured healthcare industry and access to well-designed reimbursement policies.

The dermatology diagnostic devices market stood at US$245.1 mn in North America and is projected to reach US$470.4 mn by the end of 2023, thus exhibiting a CAGR of 7.6% during the period. The dermatology therapeutics market in the region however is expected to report moderate growth in the forecast period. It is poised to surge at 2.1% CAGR between 2015 and 2023.

While Europe is expected to emerge as the second-largest market for dermatology diagnostic devices and therapeutics, the distinction of the fastest growing market will remain with Asia Pacific. The latter is expected to demonstrate the fastest CAGR of 2.4% during the forecast period. The presence of large pool of geriatric population in Asia Pacific, apart from increasing healthcare spending in the emerging economies is boosting prospects for the market in the region. The increasing government support will also prove lucrative for the enterprises operating in Asia Pacific.

Demand for Antibacterial Drugs to Surge in Response to Increasing Incidence of Chronic Skin Conditions

In the dermatology diagnostics market, the demand for imaging equipment is rising at a high pace. The segment also accounted for the dominant share of in the market in 2014 based on revenue. The lead of this product segment is largely attributed by the high price of imaging equipment. However, TMR projects the demand for high sensitivity imaging equipment to rise at a faster pace in the near future due to their proven result in diagnosis of chronic skin diseases.

By drug class, antibacterial drugs accounted for the largest share in the global dermatology therapeutics market. This segment is projected to report a CAGR of 3.3% during the forecast period. The demand for these drugs are expected to increasing in the forthcoming years because they have proven efficient treating and preventing infections. Furthermore, the demand for topical antibacterial drugs and oral antibiotics is also expected to rise in the future due to their use in the treatment of various skin conditions.

Some of the leading companies operating in the global dermatology diagnostic devices and therapeutics market include  Astellas Pharma, Inc., Agfa-Gevaert N.V., Novartis International AG, Cutera, Inc., Galderma S.A., Dino-Lite Europe/IDCP B.V., Genentech, LEO Pharma A/S, Michelson Diagnostics Ltd., Valeant Pharmaceuticals International, Inc., and others. 


Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Dermatology Diagnostic Devices and Therapeutics Market, Size and Forecast, By Revenue, 2013–2023 (US$ Mn)
2.2 Global Dermatology Diagnostic Devices Market, by Product, 2014 (US$ Mn)
2.3 Global Dermatology Therapeutics Market, by Drug Class, 2014 (US$ Mn)
2.4 Global Market Share by Geography (Diagnostic Devices), 2014 and 2023 (Value %)
2.5 Global Market Share by Geography (Therapeutics), 2014 and 2023 (Value %)
2.6 Dermatology Diagnostic Devices Market Snapshot
2.7 Dermatology Therapeutics Market Snapshot

Chapter 3 Dermatology Diagnostic Devices and Therapeutics Market Overview
3.1 Market Overview
3.2 Market Drivers
     3.2.1 Driver 1 - Rising prevalence of acute and chronic skin disorders
     3.2.2 Driver 2 - Changing patient pool demographics and increasing geriatric population
            3.2.2.1 Percentage of Population (for U.S., China, Japan, and India) over the age of 65: 1980–2050 
            3.2.2.2 Global Percentage Change in the World’s Population by Age: 2010 – 2050
3.3 Restraints
     3.3.1 Restraint 1 - Implementation of the Affordable Care Act and medical device tax
     3.3.2 Restraint 2 -Patent expirations of major drugs during the forecast period expected to impede market growth
3.4 Opportunities
     3.4.1 Opportunity 1 - Disposable income and growing patient pool in emerging markets
3.5 Porter’s Five Forces Analysis
3.6 Company Market Share
3.7 Market Attractiveness Analysis
3.8 Overview of Skin Diseases

Chapter 4 Market Segmentation – By Products
4.1 Introduction
     4.1.1 Global Dermatology Diagnostic Devices Market, by Product, 2013–2023 (US$ Mn)
4.2 Global Dermatoscopes Market Revenue for Dermatology Diagnostic, 2013–2023 (US$ Mn)
4.3 Global Microscopes and Trichoscopes Market Revenue for Dermatology Diagnostic, 2013–2023 (US$ Mn)
4.4 Global Imaging Equipment Market Revenue for Dermatology Diagnostic, 2013–2023 (US$ Mn)

Chapter 5 Market Segmentation – By Drug Class
5.1 Introduction
     5.1.1 Global Dermatology Therapeutics Market, by Drug Class, 2013–2023 (US$ Mn)
5.2 Global Antibacterials for Dermatology Market Revenue, 2013–2023 (US$ Mn)
5.3 Global Antifungal Agents for Dermatology Market Revenue, 2013–2023 (US$ Mn)
5.4 Global Antiviral Agents for Dermatology Market Revenue, 2013–2023 (US$ Mn)
5.5 Global Corticosteroids for Dermatology Market Revenue, 2013–2023 (US$ Mn)
5.6 Global Retinoids for Dermatology Market Revenue, 2013–2023 (US$ Mn)
5.7 Global Immunosuppresants for Dermatology Market Revenue, 2013–2023 (US$ Mn)
5.8 Global Biologics for Dermatology Market Revenue, 2013–2023 (US$ Mn)

Chapter 6 Market Segmentation – By Pipeline Assessment
6.1 Global Dermatology Therapeutics Market: Pipeline Overview, Phase I, II,and III
6.2 Global Dermatology Therapeutics Market, Pipeline Analysis and Forecast, Year of Launch till 2023 (US$ Mn) 

Chapter 7 Market Segmentation – By Region
7.1 Overview
     7.1.1 Global Dermatology Diagnostic Devices Market Revenue, by Geography, 2013–2023 (US$ Mn)
     7.1.2 Global Dermatology Therapeutics Market Revenue, by Geography, 2013–2023 (US$ Mn)
7.2 North America 
     7.2.1 North America Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
     7.2.2 North America Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn)
7.3 Europe
     7.3.1 Europe Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
     7.3.2 Europe Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn)
7.4 Asia Pacific
     7.4.1 APAC Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
     7.4.2 APAC Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn)
7.5 Latin America
     7.5.1 Latin America Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
     7.5.2 Latin America Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn)
7.6 Middle East & North Africa
     7.6.1 MENA Dermatology Diagnostic Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
     7.6.2 MENA Dermatology Therapeutics Market Revenue, by Country, 2013–2023 (US$ Mn)
7.7 Rest of the World
     7.7.1 RoW Dermatology Diagnostic Devices Market Revenue, 2013–2023 (US$ Mn)
     7.7.2 RoW Dermatology Therapeutics Market Revenue, 2013–2023 (US$ Mn)

Chapter 8 Historical Snapshot and Current Trends

Chapter 9 Company Profiles
9.1 Agfa-Gevaert N.V.
9.2 Astellas Pharma, Inc.
9.3 Cutera, Inc.
9.4 Dino-Lite Europe/IDCP B.V.
9.5 Galderma S.A.
9.6 Genentech, a Roche Company 
9.7 GlaxoSmithKline plc (Stiefel Laboratories, Inc.)
9.8 LEO Pharma A/S
9.9 Michelson Diagnostics Ltd.
9.10 Novartis International AG
9.11 Valeant Pharmaceuticals International, Inc.

Dermatology is a branch of medical science that deals with examination and treatment of various disorders and diseases related to the skin, hair, nails, including its surgical aspect. The stakeholders of this market report comprise established original equipment and pharmaceutical product manufacturers, product distributors, and new players who wish to enter the global dermatology diagnostic devices and therapeutics market. 

This report provides a complete analysis of the global dermatology diagnostic devices and therapeutics market and helps in recognizing several governing factors that impact the market both positively and negatively. Executive summary of the report captures comprehensive insights about every segment considered in this study. It includes a market snapshot offering an insight into the current scenario of the dermatology diagnostic device and dermatology market in terms of current and future market size along with growth rate. 

The market overview segment provides thorough information on the trends in the usage pattern of various diagnostic devices and therapeutics for dermatology, such as drivers, restraints, and growth opportunities that presently regulate the dynamics of the overall market. Competitive analysis tools such as Porter’s Five Forces analysis and market attractiveness analysis have also been incorporated in this study to provide analysis about the level of competition within the dermatology diagnostic devices and therapeutics market. Competitive intelligence tools such as market attractiveness analysis have also been included in the market overview section of the report to deliver a clear understanding of the most attractive and fastest growing device segment, drug class and region globally for dermatology diagnostic devices and therapeutics. 

Market share analysis thus provided in this study is in context with major players of dermatology diagnostic devices and dermatology therapeutics operating in the market; this would help new players to understand the key business models and geographical presence and identify the specific product lines of existing companies to establish a strong presence in the dermatology diagnostic devices and therapeutics market. Furthermore, the research comprises a chapter on pipeline analysis for this industry that includes tabular representation of phase I and phase II candidates along with sales forecast potential drugs that are undergoing phase III clinical trials and are expected to be marketed during the forecast period. 

The global dermatology diagnostic devices and therapeutics market has been segmented based on various dermatology diagnostic devices, drug classes used for treating dermatology disorders, and geographies. Based on dermatology diagnostic products the market has been categorized into dermatoscopes, microscopes & trichoscopes, and imaging equipment. Based on drug class the dermatology therapeutics market has been segmented into antibacterials, antifungal agents, antiviral agents, corticosteroids, retinoids, immunosuppresants, biologics. The market size for the period from 2013 to 2023 has been provided for each of the devices and therapeutics categories mentioned above in terms of US$ Mn. Along with the market size that was projected considering 2014 as the base year and 2013 as the historical year, the CAGR (%) of each market segment for the forecast period from 2015 to 2023 (for therapeutics forecast period is from 2013 to 2018 and 2018 to 2023) has also been provided. 

Geographically, the dermatology diagnostic devices and therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, the Middle East & North Africa, and Rest of the World. North America has been further segmented into the U.S. and Canada; Europe into Germany, the U.K. and Rest of Europe; Asia Pacific into China, Japan, India, Australia, and Rest of Asia Pacific; Latin America into Brazil and Rest of Latin America; Middle East & North Africa (MENA) into Egypt, Kuwait, UAE, Saudi Arabia, and rest of MENA; and Rest of the world. The market revenue of dermatology diagnostic devices and therapeutics for each geographical region for 2014 and 2023 along with forecast from 2015 to 2023 in respective regions in terms of USD Mn, has been explained in the geography section of the report. 

This market study concludes with profiles of key players in the global dermatology diagnostic devices and dermatology market. The report summarizes the companies in terms of overview, financial overview, product and services portfolio, key business strategies, and recent developments. The major players profiled in the section are Agfa-Gevaert N.V., Astellas Pharma, Inc., Cutera, Inc., Dino-Lite Europe/IDCP B.V., Galderma S.A., Genentech, a Roche Company, GlaxoSmithKline plc (Stiefel Laboratories, Inc.), LEO Pharma A/S, Michelson Diagnostics Ltd., Novartis International AG, and Valeant Pharmaceuticals International, Inc. 

The global dermatology diagnostic devices and therapeutics market has been segmented as follows:

Dermatology Diagnostic Devices Market, by Products

  • Dermatoscopes
  • Microscopes and Trichoscopes
  • Imaging Equipment

Dermatology Therapeutics Market, by Drug Class

  • Antibacterials
  • Antifungal Agents
  • Antiviral Agents
  • Corticosteroids
  • Retinoids
  • Immunosuppresants
  • Biologics

Dermatology Therapeutics Market: Pipeline Overview, Phase 1, 2, and 3

  • Tabular Representation: Phase 1 and Phase 2 Candidates
  • Pipeline Analysis and Forecast: Phase 3
    • LAS41008
    • Ixekizumab
    • Dupilumab
    • CD5789
    • IDP-118

Dermatology Diagnostic Devices and Therapeutics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & North Africa (MENA)
    • Egypt
    • Kuwait
    • UAE
    • Saudi Arabia
    • Rest of MENA
  • Rest of the World (RoW)